TMCnet News
Gridsum Announces Full Exercise of Underwriters' Option to Purchase Additional ADSsBEIJING, Sept. 30, 2016 (GLOBE NEWSWIRE) -- Gridsum Holding Inc. (“Gridsum” or the “Company”) (NASDAQ:GSUM), a leading provider of sophisticated data analysis software in China, today announced that the underwriters of its previously announced initial public offering have exercised in full the option to purchase an additional 1,005,000 American depository shares (“ADSs”) from the Company to cover over-allotments. Each ADS represents one Class B ordinary share of the Company and will be sold at the initial public offering price of US$13.00 per ADS. Including the full exercise of the over-allotment option, the Company expects to raise a total of approximately U$100.2 million in gross proceeds from the initial public offering. The settlement date for the additional ADSs will be around 10:00 a.m., New York City time, on October 3, 2016. Goldman Sachs (Asia) L.L.C., Citigroup Global Markets Inc. and Stifel, Nicolaus & Company, Incorporated acted as joint bookrunners for the offering. Gridsum’s registration statement relating to these securities has been filed with the United States Securities and Exchange Commission and was declared effective on September 22, 2016. This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities, in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering of the securities is made only by means of a prospectus forming a part of the effective registration statement. A copy of the final prospectus relating to the offering may be obtained, when available, by contacting Goldman, Sachs & Co. at 1-212-902-1171, Citigroup Global Markets Inc. at 1-800-285-3000, or Stifel, Nicolaus & Company, Incorporated at 1-415-364-2720. Investor Relations: ICR, Inc. Violet Gu Tel: +1 (646) 328-2510 Email: [email protected] |